Breaks Categories: Stock Spotlights

MondayApr 02, 2018 2:13 pm

CannabisNewsBreaks – Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Aims to Become Canada’s Premier Cannabis Brand

British Columbia-based cannabis cultivation firm Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) is positioning itself to make the most of the Canadian cannabis industry’s anticipated spike. An article discussing the company reads: “Choom™ is targeting nothing less than becoming the premier recreational cannabis brand in Canada. With its fully-integrated business model, the company aims to be the seed-to-sale market leader in reaching the Canadian cannabis consumer. Choom™ intends to become a leading Canadian cannabis grower and will be developing a chain of high-end branded retail cannabis dispensaries in strategic Canadian jurisdictions. Choom™ retail stores will provide discriminating cannabis consumers a…

Continue Reading

ThursdayMar 29, 2018 3:43 pm

CannabisNewsBreaks – Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) Strives to Attain GMP-compliant Procedures

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) continues to diversify its portfolio as the Canadian government prepares to legalize cannabis-infused edibles and beverages by mid-2019. An article discussing the company reads: “Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P), a vertically-integrated cannabis company with strategic investments in proven, revenue-generating businesses, is building a diversified portfolio that includes marketing a wide range of high quality, medicinal grade cannabis products with tremendous promise for both human and veterinary use. Liberty Leaf and its wholly owned subsidiary, North Road Ventures, recently signed an agreement with Cannabis Compliance Inc.…

Continue Reading

ThursdayMar 29, 2018 3:38 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Anticipates Additional Technology Licensing Contracts in 2018

Lexaria Bioscience’s (CSE: LXX) (OTCQB: LXRP) CEO Chris Bunka recently discussed the company’s plans regarding technology licensing contracts in an audio interview. An article further discussing the company reads: “LXRP is a British Columbia, Canada-based bioscience company that is a drug delivery platform innovator. The company has developed its patented DehydraTECH™ delivery technology platform, which it out-licenses to promote healthier ingestion methods and lower overall dosing. …Bunka said that LXRP believes that 6-12 more licensing contracts will be signed this year, both generating more revenue for the company and building greater shareholder value. “We’ve only just graduated from the demonstration…

Continue Reading

ThursdayMar 29, 2018 12:35 pm

CannabisNewsBreaks – Earth Science Tech, Inc. (ETST) Expands Presence in Blossoming Hemp-Based CBD Market

Earth Science Tech (OTC: ETST), an innovative biotech company focused on the cannabidiol (“CBD”), nutraceutical and pharmaceutical fields, is on track to increase growth and broaden its presence in the cannabis industry. An article discussing the company reads: “The worldwide cannabidiol (CBD) oil market, which includes products derived from both marijuana and hemp, is projected to grow at a CAGR of more than 39 percent through 2021. The health benefits of CBD oil are the major driver for growth in this market, with global demand steadily on the rise in recent years. Hemp-based CBD oil products in particular are more…

Continue Reading

ThursdayMar 29, 2018 12:28 pm

CannabisNewsBreaks – Medical Cannabis Payment Solutions (REFG) Enables Electronic Transactions in Legal Cannabis Industry via Green Platform

Cannabis-focused financial services company Medical Cannabis Payment Solutions (OTC: REFG) has developed the Green platform, a top tier digital payment processing system that offers ease of cash management to merchants while enabling consumers and patients to purchase electronically, even with cryptocurrency. An article discussing the company’s platform reads: “Among its key advantages are the money management system and the simple signup feature for consumers. Not only is it FinCEN-compliant, Green offers both merchants and customers an enticing platform to manage money for sellers and financial services for buyers. … For merchants, it can be integrated with most any existing point-of-sale…

Continue Reading

TuesdayMar 27, 2018 2:51 pm

CannabisNewsBreaks – EVIO, Inc. (EVIO) Testing Services Thrive in Booming Cannabis Sector

EVIO, Inc. (OTCQB: EVIO), a life sciences and cannabis testing company, continues to thrive in the flourishing cannabis industry. An article discussing the company reads: “Cannabis testing services like those offered by EVIO currently comprise about five percent of the total marijuana market, which is projected to reach $31.4 billion globally by 2021 (http://cnw.fm/0ZSs5). Ancillary services to the cannabis market make an attractive investment opportunity that is considered more reliable in many ways than investing in the plant directly. EVIO’s offerings further add the inducement that cannabis testing is mandatory and will continue to be so, making this particular segment…

Continue Reading

MondayMar 26, 2018 3:35 pm

CannabisNewsBreaks – Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Prepares to Pounce on Canada’s Recreational Cannabis Market Following Upcoming Legalization

British Columbia-based cannabis cultivation firm Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) is currently planning its expansion strategy as the end of cannabis prohibition in Canada approaches. An article discussing the company reads: “According to the company’s investor presentation made in November, by 2021, the recreational marijuana industry that Choom™ Holdings exclusively aims to serve is expected to be almost eight times the size of the medical marijuana industry, which is served by Choom’s Medi-Can Health Solutions Ltd. subsidiary, with benefits spilling over into the tourism industry, governmental tax and licensing coffers, and paraphernalia manufacturing market. Its nimble business model…

Continue Reading

FridayMar 23, 2018 12:16 pm

CannabisNewsBreaks – Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Capitalizing on the Vast Market Potential of Hemp, CBD Products

Hemp cultivation company Global Hemp Group (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) remains primarily focused on the cultivation of hemp and cannabinoid extraction for both domestic and international markets. An article discussing the company reads: “Founded in 2014, Global Hemp Group is building a strategic portfolio of hemp-based companies to provide its global customer base with a consistent supply of high-quality hemp-derived products. It intends to leverage the huge market potential of hemp products to deliver significant ROI to its shareholders. The number of products that can be manufactured from the hemp plant is vast. It can be used to…

Continue Reading

FridayMar 23, 2018 12:09 pm

CannabisNewsBreaks – Marijuana Company of America, Inc. (MCOA) Offers a Natural Option for Pet Owners with hempSMART Full Spectrum Pet Drops

Innovative hemp and cannabis corporation Marijuana Company of America (OTC: MCOA) recently launched its new CBD-based natural pet product, hempSMART™ Full Spectrum Pet Drops. An article discussing the company’s new pet product line reads: “MCOA’s hempSMART™ Full Spectrum Pet Drops for cats and dogs are formulated with 250mg of full spectrum non-psychoactive cannabidiol (CBD) derived from industrial hemp. The new, specially-formulated product contains naturally-occurring CBD derived from hemp seed oil, full spectrum hemp extract, fractionated coconut oil and a rich bacon flavor that pets will love. The new Full Spectrum Pet Drops add a new vertical to MCOA’s fast growing…

Continue Reading

FridayMar 23, 2018 11:22 am

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Technology Mimics the Body’s Natural Creation of Pain Fighting Peptides

Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is engaged in the development of pain relievers that mimic body’s natural pain relief peptides. An article discussing the company reads: “The linker technology that underlies PreveCeutical’s drug development platform was developed at the University of Queensland in Australia. At that impressive institution, Dr. Parekh headed a team that developed synthetic molecules capable of mimicking the endomorphins produced by the body for pain relief, as explained by PreveCeutical chairman and CEO Stephen Van Deventer in a recent video interview (http://cnw.fm/fEO5a). Although they are as potent as morphine, the effect…

Continue Reading